Fujitsu, NCC to create new services for clinical trials, drug development in Japan
Drug Discovery | News | 0 Comment | 18 Mar, 2021
Fujitsu has announced it has concluded a comprehensive collaborative research agreement with National Cancer Center Japa...Read more
Eisai aims for novel drug discovery for neurodegenerative disorders
Drug Discovery | News | 0 Comment | 17 Mar, 2021
German firm Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE) and Japan based Eisai have announced that b...Read more
QBiotics joins TDM Growth Partners to accelerate drug development timelines
Drug Discovery | News | 0 Comment | 16 Mar, 2021
QBiotics Group Limited, a Brisbane (Australia) life sciences company developing novel anticancer and wound healing pharm...Read more
Boehringer Ingelheim to develop innovative Peptides to treat Obesity
Drug Discovery | News | 0 Comment | 01 Mar, 2021
Boehringer Ingelheim and Gubra on March, 1st 2021 announced a new research and licensing agreement focused on ...Read more
HitGen, UPPTHERA collaborate for drug discovery research
Drug Discovery | News | 0 Comment | 02 Mar, 2021
Chinese firm HitGen has announced that it has entered into a drug discovery research collaboration with UPPTHERA Inc to ...Read more
Insilico Medicine discovers industry first preclinical drug candidate using AI
Drug Discovery | News | 1 Comment | 25 Feb, 2021
China based Insilico Medicine has demonstrated a breakthrough in Artificial Intelligence ("AI") and drug disco...Read more
China's Suntrap discovers LeSoleil to fight COVID-19 and future epidemics
Drug Discovery | News | 0 Comment | 15 Feb, 2021
AI-assisted computing has greatly improved the efficiency of new drug research and development. China's Suntrap Life Tec...Read more
The Next-generation antimalarial treatment designed to tackle the drug-resistance challenge
Drug Discovery | Opinion | 2 Comment | 09 Feb, 2021
Since the previous century, Tropical and subtropical regions have been grappling under the parasitic...Read more
Korea approves first anti-COVID-19 monoclonal antibody treatment
Drug Discovery | News | 0 Comment | 08 Feb, 2021
Celltrion Group has announced that the Ministry of Food and Drug Safety (MFDS) of South Korea has granted conditional ma...Read more
India's Biocon Biologics to offer Oncology Biosimilars in over 30 countries
Drug Discovery | News | 0 Comment | 05 Feb, 2021
Biocon Biologics Ltd., a fully integrated ‘pure-play’ biosimilars company and a subsidiary of Bioc...Read more
Hong Kong develops formula for treating Alzheimer's disease
Drug Discovery | News | 0 Comment | 05 Feb, 2021
Researchers from the School of Chinese Medicine (SCM) at Hong Kong Baptist University (HKBU) have developed a ...Read more
Genesis Medtech collaborates with Penumbra to expand Neurovascular market in China
Drug Discovery | News | 0 Comment | 20 Jan, 2021
Genesis MedTech Group has reached a consensus to fully acquire Hua Medtech as part of its plans to set up a specialise...Read more
Mitsubishi Tanabe & Takeda to accelerate data-driven drug discovery
Drug Discovery | News | 0 Comment | 19 Jan, 2021
Japanese firm Mitsubishi Tanabe Pharma Corporation (MTPC) has announced that MTPC and Takeda Pharmaceutical Company...Read more
Sosei and PharmEnable enter technology collaboration for AI-driven drug discovery
Drug Discovery | News | 0 Comment | 12 Jan, 2021
Sosei Group Corporation (Sosei Heptares) in Japan and PharmEnable, a UK drug discovery company, have announced...Read more
Fujifilm injects $2B into large-scale cell culture manufacturing site in US
Drug Discovery | News | 0 Comment | 08 Jan, 2021
FUJIFILM Corporation is making an investment of more than 200 Billion yen ($2 Billion) to establish a new...Read more
Y-Biologics, 3D Medicines collaborate to develop novel cancer therapeutics for China
Drug Discovery | News | 0 Comment | 06 Jan, 2021
The South Korean biotech company Y-Biologics and the China-based biopharmaceutical company 3D Medicines have entere...Read more
Singapore launches spin-off to develop treatment for intractable diseases
Drug Discovery | News | 0 Comment | 24 Dec, 2020
The Experimental Drug Development Centre (EDDC), a national platform for drug discovery and development hosted by A*STAR...Read more
Antengene submits NDAs for XPOVIO (Selinexor) in multiple APAC markets
Drug Discovery | News | 0 Comment | 04 Dec, 2020
Antengene Corporation Limited, a leading innovative biopharmaceutical company dedicated to discovering, developing and c...Read more